
Umamaheswari Ramachandran
Examiner (ID: 1992, Phone: (571)272-9926 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627, 1617 |
| Total Applications | 1598 |
| Issued Applications | 702 |
| Pending Applications | 154 |
| Abandoned Applications | 762 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9857309
[patent_doc_number] => 20150037326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen'
[patent_app_type] => utility
[patent_app_number] => 14/375392
[patent_app_country] => US
[patent_app_date] => 2013-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 45230
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14375392
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/375392 | Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen | Jan 29, 2013 | Abandoned |
Array
(
[id] => 11236610
[patent_doc_number] => 09463241
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-11
[patent_title] => 'Method for stabilising an immunoglobulin G composition in liquid form'
[patent_app_type] => utility
[patent_app_number] => 13/752189
[patent_app_country] => US
[patent_app_date] => 2013-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5326
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13752189
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/752189 | Method for stabilising an immunoglobulin G composition in liquid form | Jan 27, 2013 | Issued |
Array
(
[id] => 9551717
[patent_doc_number] => 08758763
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'Archaeal polar lipid aggregates for administration to animals'
[patent_app_type] => utility
[patent_app_number] => 13/748412
[patent_app_country] => US
[patent_app_date] => 2013-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 63
[patent_no_of_words] => 38276
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13748412
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/748412 | Archaeal polar lipid aggregates for administration to animals | Jan 22, 2013 | Issued |
Array
(
[id] => 10600249
[patent_doc_number] => 09320797
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-26
[patent_title] => 'Pharmaceutical formulations'
[patent_app_type] => utility
[patent_app_number] => 13/742818
[patent_app_country] => US
[patent_app_date] => 2013-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16943
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13742818
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/742818 | Pharmaceutical formulations | Jan 15, 2013 | Issued |
Array
(
[id] => 10945831
[patent_doc_number] => 20140348852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'METHOD FOR MAKING PRECIPITATED PARTICLES'
[patent_app_type] => utility
[patent_app_number] => 14/367088
[patent_app_country] => US
[patent_app_date] => 2012-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11691
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14367088
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/367088 | METHOD FOR MAKING PRECIPITATED PARTICLES | Dec 23, 2012 | Abandoned |
Array
(
[id] => 8989340
[patent_doc_number] => 20130216621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'BIFUNCTIONAL CONJUGATE COMPOSITIONS AND ASSOCIATED METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/725524
[patent_app_country] => US
[patent_app_date] => 2012-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 16381
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13725524
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/725524 | BIFUNCTIONAL CONJUGATE COMPOSITIONS AND ASSOCIATED METHODS | Dec 20, 2012 | Abandoned |
Array
(
[id] => 8950071
[patent_doc_number] => 20130195851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'ARTICLES OF MANUFACTURE AND METHODS FOR CO-ADMINISTRATION OF ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 13/723889
[patent_app_country] => US
[patent_app_date] => 2012-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 30607
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13723889
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/723889 | ARTICLES OF MANUFACTURE AND METHODS FOR CO-ADMINISTRATION OF ANTIBODIES | Dec 20, 2012 | Abandoned |
Array
(
[id] => 9003088
[patent_doc_number] => 20130224213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'Compositions and Methods for Stabilizing Protein-Containing Formulations'
[patent_app_type] => utility
[patent_app_number] => 13/722559
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 18652
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13722559
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/722559 | Compositions and methods for stabilizing protein-containing formulations | Dec 19, 2012 | Issued |
Array
(
[id] => 10136004
[patent_doc_number] => 09169317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-27
[patent_title] => 'Method of altering the binding specificity of plasma proteins by oxidation-reduction'
[patent_app_type] => utility
[patent_app_number] => 13/712151
[patent_app_country] => US
[patent_app_date] => 2012-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 40
[patent_no_of_words] => 11899
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13712151
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/712151 | Method of altering the binding specificity of plasma proteins by oxidation-reduction | Dec 11, 2012 | Issued |
Array
(
[id] => 8744578
[patent_doc_number] => 20130084295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-04
[patent_title] => 'ANTI-INTERFERON-ALPHA ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 13/692952
[patent_app_country] => US
[patent_app_date] => 2012-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 33327
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13692952
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/692952 | ANTI-INTERFERON-ALPHA ANTIBODIES | Dec 2, 2012 | Abandoned |
Array
(
[id] => 10932064
[patent_doc_number] => 20140335084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-13
[patent_title] => 'ANTIBODY FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 14/363103
[patent_app_country] => US
[patent_app_date] => 2012-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25026
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14363103
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/363103 | ANTIBODY FORMULATION | Dec 2, 2012 | Abandoned |
Array
(
[id] => 12523575
[patent_doc_number] => 10004689
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions
[patent_app_type] => utility
[patent_app_number] => 13/261883
[patent_app_country] => US
[patent_app_date] => 2012-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 8310
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13261883
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/261883 | Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions | Nov 13, 2012 | Issued |
Array
(
[id] => 9676327
[patent_doc_number] => 08815236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-26
[patent_title] => 'Method for treating multiple sclerosis and crohn\'s disease'
[patent_app_type] => utility
[patent_app_number] => 13/676866
[patent_app_country] => US
[patent_app_date] => 2012-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8913
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13676866
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/676866 | Method for treating multiple sclerosis and crohn's disease | Nov 13, 2012 | Issued |
Array
(
[id] => 14551633
[patent_doc_number] => 10344261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-09
[patent_title] => Immunomodulatory conjugates
[patent_app_type] => utility
[patent_app_number] => 14/357520
[patent_app_country] => US
[patent_app_date] => 2012-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 63
[patent_no_of_words] => 30632
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14357520
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/357520 | Immunomodulatory conjugates | Nov 8, 2012 | Issued |
Array
(
[id] => 8927928
[patent_doc_number] => 20130183688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'TIM-3 LIGANDS AND METHODS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/670096
[patent_app_country] => US
[patent_app_date] => 2012-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 43882
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13670096
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/670096 | TIM-3 LIGANDS AND METHODS THEREOF | Nov 5, 2012 | Abandoned |
Array
(
[id] => 8696949
[patent_doc_number] => 20130058958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'COMPOSITIONS AND METHODS USEFUL FOR REDUCING THE VISCOSITY OF PROTEIN-CONTAINING FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/666990
[patent_app_country] => US
[patent_app_date] => 2012-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19776
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13666990
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/666990 | COMPOSITIONS AND METHODS USEFUL FOR REDUCING THE VISCOSITY OF PROTEIN-CONTAINING FORMULATIONS | Nov 1, 2012 | Abandoned |
Array
(
[id] => 9350044
[patent_doc_number] => 08668935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-11
[patent_title] => 'Method and composition for hyperthermally treating cells'
[patent_app_type] => utility
[patent_app_number] => 13/665458
[patent_app_country] => US
[patent_app_date] => 2012-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20788
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13665458
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/665458 | Method and composition for hyperthermally treating cells | Oct 30, 2012 | Issued |
Array
(
[id] => 8939914
[patent_doc_number] => 20130189711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'METHODS, PRODUCTS AND TREATMENTS FOR DIABETES'
[patent_app_type] => utility
[patent_app_number] => 13/662610
[patent_app_country] => US
[patent_app_date] => 2012-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10531
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13662610
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/662610 | METHODS, PRODUCTS AND TREATMENTS FOR DIABETES | Oct 28, 2012 | Abandoned |
Array
(
[id] => 9970667
[patent_doc_number] => 09017671
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-28
[patent_title] => 'Method of treating cancer with a pharmaceutical formulation comprising a HER2 antibody'
[patent_app_type] => utility
[patent_app_number] => 13/660114
[patent_app_country] => US
[patent_app_date] => 2012-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 44
[patent_no_of_words] => 40995
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13660114
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/660114 | Method of treating cancer with a pharmaceutical formulation comprising a HER2 antibody | Oct 24, 2012 | Issued |
Array
(
[id] => 10114643
[patent_doc_number] => 09149508
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-10-06
[patent_title] => 'Vaccination by circumventing preexistent immunity'
[patent_app_type] => utility
[patent_app_number] => 13/660035
[patent_app_country] => US
[patent_app_date] => 2012-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6756
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13660035
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/660035 | Vaccination by circumventing preexistent immunity | Oct 24, 2012 | Issued |